Market revenue in 2023 | USD 456.5 million |
Market revenue in 2030 | USD 2,418.2 million |
Growth rate | 26.9% (CAGR from 2023 to 2030) |
Largest segment | Pcr technology |
Fastest growing segment | NGS Technology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.45% in 2023. Horizon Databook has segmented the India synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Indian companies are promoting synthetic biology and have adopted different approaches in funding, promotion, and regulation. They are developing a wide range of applications, from biofuels to industrial enzymes.
Some of the major companies are hybrid seed producers, with rapid adoption of GM crops in the country, making it the largest producer of Bt cotton. Moreover, large private companies such as Reliance Industries Limited are adding synthetic biology to their technology portfolios.
This factor indicates that large companies in the country recognize synthetic biology applications as a technology worth pursuing. Furthermore, the Indian government is aware of the importance of synthetic biology. It began two national initiatives—the National Biopharma Mission and the National Biofuel Policy. These initiatives are promoting R&D in biopharma & biofuels.
Horizon Databook provides a detailed overview of country-level data and insights on the India synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into India synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account